ETEX Corporation Announces CE Mark of Beta-bsm and Gamma-bsm
...ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minim...Orthomimetics Secures CE Mark Approval for Chondromimetic
... CAMBRIDGE, England, January 14 /PRNewswire/ -- This approval enables the company to market its line of bioresorbable implants for bone and/or soft tissue repair in the EU. Orthomimetics' family of products was developed during a groundbreaking collaboration between t...TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope
... environment for implanted CRMD devices. The AIGISRx CRMD technology is constructed of knitted filaments of polypropylene coated with a proprietary bioresorbable polymer that elutes the antimicrobial agents rifampin and minocycline for a minimum of seven days. In in vitro studies, AIGIS Rx CRMD has demonst...SyntheMed Appoints Corinne Mundin as Director, International Market Development
... these surgeries are secondary procedures. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over the surface of the heart a...ment and expansion of product development programs based on its proprietary bioresorbable polymer technology. Statements in this Press Release that are not stateme...SyntheMed, Inc. Adopts Shareholder Rights Plan
...nd other surgical implants. The company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology. Statements in this Press Release that are not statements of historical fact, constitute "forward-looking statements" within the ...SyntheMed to Present at 2007 Lazard Capital Markets Fourth Annual Healthcare Conference
...and drug delivery products. The company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology. ...FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
...of these surgeries are secondary procedures. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over the surface of the heart a...ment and expansion of product development programs based on its proprietary bioresorbable polymer technology. Statements in this Press Release that are not statemen...Research for Back Pain Relief Strikes Gold
...of ‘’bioresorbable’’ polymer scaffolds. These scaffolds when surgically implanted are to hold tissues together hastening cell repair and regeneration. bioresorbable scaffolding, which in due time dissolves is beneficial to patients in the long run as they hasten the healing process and therefore, cuts time and cos...Kensey Nash Announces IDE Submission for Cartilage Repair Device
...mpany's Cartilage Repair Device, which consists of a proprietary bi-phasic, bioresorbable implant designed to treat chondral lesions. Articular cartilage injur... The Company's Cartilage Repair Device (CRD) is a composite of several bioresorbable biomaterials, utilizing the Company's proprietary collagen technology, and ...SyntheMed Receives Canadian Approval for REPEL-CV(R)
...erious complication in secondary surgical procedures, increasing the length, cost and risk of the surgical procedure. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over the surface of the heart at the conclusion of an open-heart surgical procedure to reduce the extent a...Osteomesh Bioresorbable Implant for Craniofacial Surgery
Description: Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with...Osteoplug Bioresorbable Implant for Trephination Burr Holes
Description: Posteoplug is a bioresorbable implant that is used for covering trephination burr holes in neurosurgery. This proprietary, user-friendly design, shaped like a flattened button mushroom, allows a snap fit into burr holes and requires no fixation by screws, unlike titanium plates. It has superior me...Sepramesh Biosurgical Composite
Description:... Shortly after placement of Sepramesh, the coated side of the mesh becomes a hydrated gel that is slowly resorbed into the body within one week. The bioresorbable barrier separates the mesh from underlying organs while a protective cell layer forms over the mesh. The composite design encourages complete tissue i...BioTwist RC Soft Tissue Anchor System
Description:... The BioTwist RC implant is molded from Poly-L-Lactide Acid (PLLA) and retains the benefits of bioresorbable fixation, which include radiolucency and a history of clinical effectiveness and safety. The simple screw-in method of insertion reduces vario...SyntheMed Completes $2.8 Million Equity Financing
..., Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products based on its proprietary bioresorbable polymer technology. Statements in this Press Release that are not statements of historical fact, including statements regarding indications of the ti...FDA approves first medical device using rutgers biomaterial
...erials help the body to repair itself and are then resorbed. The device consists of a surgical mesh coated with a polymer developed using a Rutgers bioresorbable technology. The polymer gives the surgical mesh improved handling characteristics that facilitate precise placement during the surgical repair and lea...REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart
...i-adhesion products, announced today that REPEL-CV bioresorbable Adhesion Barrier has received the endorsement of K...ocedure. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over t...y focused on the commercialization of REPEL-CV(TM) bioresorbable Adhesion Barrier and the advancement and expansion...Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
...ical trial, which is expected to start later this year, will utilize the Company's Cartilage Repair Device, which consists of a proprietary bi-phasic, bioresorbable implant designed to treat chondral lesions. The Company recently submitted a design dossier for CE Mark approval for its cartilage repair device; appr...SyntheMed Receives US Patent on Novel Polymer Technology
...een awarded US Patent #7,569,643 pertaining to its bioresorbable reverse thermal gelation polymer technology. This...y focused on the commercialization of REPEL-CV(TM) bioresorbable Adhesion Barrier and the advancement and expansion...duct development programs based on its proprietary bioresorbable polymer technologies. Statements in this P...SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
... in recognition of the development of REPEL-CV(TM) bioresorbable Adhesion Barrier. The award is presented annually...development. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over t...duct development programs based on its proprietary bioresorbable polymer technology. About Frost and Sullivan...SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
...ucts, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesio...procedure. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over t...duct development programs based on its proprietary bioresorbable polymer technology. Statements in this Pres...FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
... pediatric cardiac surgery patients. REPEL-CV is a bioresorbable film designed to be placed over the surface of the...procedure. About REPEL-CV REPEL-CV is a bioresorbable adhesion barrier film designed to be placed over t...duct development programs based on its proprietary bioresorbable polymer technology. Statements in this Pres...SyntheMed Announces FDA Clearance of SinusShield(TM)
... FDA 510(k) clearance to market SinusShield(TM), a bioresorbable membrane intended to prevent post-operative adhesi... About SinusShield(TM) SinusShield is a bioresorbable polymer membrane indicated for use in patients und...d other surgical implants based on its proprietary bioresorbable polymer technology. The company is developing a po...The Micell Rapid Absorption Polymer DES System to be Presented at TCT 2008
...scular Therapeutics (TCT) conference in Washington, DC, on October 13, 2008. The MiStent(TM), a drug-eluting stent in pre-clinical studies, utilizes a bioresorbable polymer coating that delivers the potential therapeutic benefits of the drug during the healing process. The drug and polymer are both eliminated from...